Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Chronobiology International|April 19, 2002
Circadian concepts in normal and neoplastic breastB CoudertBulletin Du Cancer|January 1, 1996
[Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or]B Coudert, G Chaplain, C Milan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2007
Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analoguesP Fumoleau, B Coudert, N Isambert, et al.Agressologie: Revue Internationale De Physio-Biologie Et De Pharmacologie Appliquees Aux Effets De L'Agression|January 1, 1991
[Reflections on the management of suspected recent pulmonary embolism]L Jeannin, B Coudert, S Lacroix, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|May 1, 1986
[Congenital paravertebral arteriovenous fistulae in children and adolescents]A Petit, B Coudert, P Louis, et al.British Journal of Cancer|August 1, 1987
Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cellsB Chauffert, D Rey, B Coudert, et al.Bulletin Du Cancer|November 26, 1999
Changing practice in systemic breast cancer adjuvant treatment in a well-defined French populationG Chaplain, B Coudert, C Milan, et al.International Journal of Oncology|May 3, 2011
p53 gene alterations are associated with a decreased responsiveness to neoadjuvant chemotherapy in human breast cancerS Lizardnacol, B Coudert, J Riedinger, et al.European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
It's time for chronotherapy!B Coudert, C Focan, E Donato di Paola, et al.Journal of Oncology|June 6, 2013
Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant TherapyS Guiu, M A Mouret Reynier, M Toure, et al.Pageof 7